Delivery Order SPE2DE23D0008-SPE2D626F99F4
Award Date 1/7/26
Potential Completion Date 1/13/26
Potential Value $3K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Fixed Price with Economic Price Adjustment
Place of Performance
Irvine, CA 92612, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Allergan USA Inc., a subsidiary of AbbVie Inc., has been awarded a delivery order valued at $1,495.00 for Natrelle TE Smooth 133S-MX-14-T breast implants. This fixed-price contract with economic price adjustment was awarded on November 20, 2025, with an ultimate completion date of November 24, 2025, and will be performed in Irvine, California. The contract was funded by the Medical Supply Chain division of the Defense Logistics Agency and carries no set-aside designation, reflecting Allergan's...
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a delivery order valued at $1,495.00 on September 2, 2025, for the supply of Natrelle TE Smooth 133S-MX-13-T breast implants. This fixed-price contract with economic price adjustment is funded by the Medical Supply Chain division of the Defense Logistics Agency Troop Support Medical and is scheduled for completion by September 4, 2025. The contract carries no set-aside designation, reflecting Allergan's status as a sole-source...
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a $1,495.00 fixed-price delivery order for Natrelle TE Smooth 133S-MX-15-T breast implants on December 1, 2025, with an ultimate completion date of December 3, 2025. The contract was issued without a set-aside designation and represents a child order under one of Allergan's existing Indefinite Delivery/Indefinite Quantity (IDV) contracts with the Defense Logistics Agency Troop Support Medical. The place of performance is Irvine,...
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a delivery order valued at $2,990.00 by the Defense Logistics Agency's Medical Supply Chain division for Natrelle TE Smooth 133S-MV-13-T breast implants. Awarded on January 7, 2026, with an ultimate completion date of January 9, 2026, this fixed-price delivery order with economic price adjustment carries no set-aside designation, reflecting Allergan's position as a sole-source provider of specialized surgical devices to federal...
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a delivery order valued at $23,920 by the Defense Logistics Agency's Medical Supply Chain division on December 12, 2025, for Natrelle TE Smooth 133S-FV-12-T breast implants. The contract is structured as a fixed-price agreement with economic price adjustment and carries an ultimate completion date of December 16, 2025. The award was made without a set-aside designation, reflecting Allergan's status as a sole-source provider of these...
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a $1,495 fixed-price delivery order (contract number 4570063968) for Natrelle TE Smooth 133S-MV-15-T breast implants on November 20, 2025, with an ultimate completion date of November 24, 2025. The award was made without a set-aside designation and will be performed in Irvine, California. Funding is provided by the Medical Supply Chain division of the Defense Logistics Agency Troop Support Medical, which procures specialized surgical...
- Allergan USA Inc., a subsidiary of AbbVie Inc., received a fixed-price delivery order valued at $2,990.00 for Natrelle TE Smooth 133S-MV-13-T breast implants from the Defense Logistics Agency Troop Support Medical division on January 7, 2026, with an ultimate completion date of February 6, 2026. This delivery order was awarded without a set-aside designation and represents a child contract under one of Allergan's larger Indefinite Delivery Vehicle agreements. The place of performance is...
- Allergan USA Inc., a subsidiary of AbbVie Inc., received a $2,990 fixed-price delivery order with economic price adjustment for Natrelle TE Smooth 133S-MV-12-T breast implants. The contract was awarded on January 7, 2026, with a completion date of January 13, 2026, and will be performed in Irvine, California. The award carries no small business set-aside designation, reflecting Allergan's status as a sole-source provider of these specialized medical devices to the federal government. This...
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a fixed-price delivery order valued at $3,404.00 for Natrelle TE Smooth 133S-MX-14-T breast implants on July 24, 2025. This delivery order, issued without set-aside designation, represents a child contract under Allergan's larger Indefinite Delivery Vehicle (IDV) agreements with the Defense Logistics Agency (DLA) Troop Support Medical. The contract is funded through the Medical Supply Chain division of DLA and involves fixed-price...
- Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a $2,814 fixed-price delivery order for Natrelle Inspira SCM 330cc breast implants by the Defense Logistics Agency (DLA) Troop Support Medical on September 5, 2025. This delivery order, which has no set-aside designation, is a child contract stemming from one of Allergan's larger Indefinite Delivery Vehicles—specifically the $13.5 million Natrelle breast implants and surgical devices IDV established on December 8, 2022. The order is...